Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03375294 · ClinicalTrials.gov registry record · Phase 2
Exploring Nitrous Oxide Effects for Post Traumatic Stress Disorder (PTSD)
A Phase 2 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT03375294: Completed Phase 2 study, sponsored by Stanford University.
NCT03375294 is a Phase 2 study that has completed, run by Stanford University. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03375294, a Phase 2 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to understand nitrous oxide effects in post traumatic stress disorder (PTSD)
Interventions
- DRUG Nitrous Oxide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2018-04-01 |
| Est. Completion | 2020-04-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03375294
The ClinicalTrials.gov registry entry for NCT03375294 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nitrous Oxide is the first listed.
NCT03375294 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03375294 about?
NCT03375294 is a clinical study titled "Exploring Nitrous Oxide Effects for Post Traumatic Stress Disorder (PTSD)". The purpose of this study is to understand nitrous oxide effects in post traumatic stress disorder (PTSD)
What is the current status of trial NCT03375294?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2018-04-01. Estimated completion is 2020-04-05.
What interventions are being tested in trial NCT03375294?
The interventions under investigation include: Nitrous Oxide (DRUG).
Who is sponsoring clinical trial NCT03375294?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.